Bradley Pharmaceuticals CEO Daniel Glassman talks to The Wall Street Transcript.

NEW YORK--(BUSINESS WIRE)--March 8, 1999--The Wall Street Transcript has published an in-depth interview with Daniel Glassman of Bradley Pharmaceuticals (Nasdaq:BPRX), in which he talks at length about his company's future.

He says, "Bradley products are distributed throughout the United States as well as in more than 25 countries around the world. The Company's primary emphasis is to actively engage in product life cycle management, and the extension of the life cycle, through marketing, including promotion, sales efforts, and improved distribution of these newly acquired products."

He explains, "The promotional mix used to maximize the life cycle is spearheaded by our 75-person field sales operation directed to high volume prescribing physicians and supported by journal advertising, direct mail, sample fulfillment and conventions. Many brands that we have acquired grow as much as 20 or 30 percent annually."

He asserts, "In addition to acquiring products, we have, over the past years, developed some of our own products. Besides developing new brands such as ENTsol(R) Hypertonic Nasal Wash system of products, which is a new Bradley drug-free treatment to relieve sinusitis, we also have successfully launched line extensions of existing brands."

Looking forward, he states, "Every one of the companies in our peer group rocketed to success following one key event or acquisition. We believe that that opportunity will occur for us as well. We're profitable; we've been profitable for the last three years; our gross margins are there; we have a well organized internal staff and field staff; we're pursuing the proper acquisition to take this company to new higher levels. And we believe now, with the financing in place, that these opportunities can and will be presented to us and we'll be able to move ahead very strongly."

To read the complete interview, go to http://www.twst.com/ceos.htm. The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations.

The Wall Street Transcript is a premier weekly investment publication serving serious long-term investors for over 35 years. The Transcript publishes industry roundtables and interviews with Wall Street analysts, money managers, and Company CEOs, and is read by top money managers, brokers, and individual investors. For subscription information call [phone].